Global Contract Manufacturing Market on Track for $968.7 Billion by 2030
"With rising demand across pharma, electronics, and automotive sectors, contract manufacturing offers cost savings, supply chain stability, and access to...
Neurology
The Dawn of Medical Superintelligence: ATLAS AI
In a Breakthrough Study ATLAS AI Outperforms Clinicians and ChatGPT in Medical Diagnoses While Slashing Unnecessary Tests LOS ANGLES, Aug....
CRC Becomes Accredited Medidata Rave® EDC Partner
ST. PETERSBURG, Fla., Aug. 12, 2025 /PRNewswire/ -- Cognitive Research Corporation (CRC), a full-service CRO specializing in neuroscience, has officially...
SamaCare Ranks No. 578 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
This Marks SamaCare's Second Time on the List, Ranking in the top 12% of America's Fastest-Growing Companies SAN FRANCISCO, Aug. 12,...
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome
– Global, pivotal Phase 3 study will evaluate efficacy and safety of zorevunersen compared to sham over a 52-week treatment...
ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance
Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on...
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025
Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update...
Creyos Expands Session Notes to Turn Cognitive Health Testing Into Timely Clinical Action
Developed by world-renowned neuroscientist Professor Adrian Owen, Creyos helps providers detect cognitive impairment through a scientifically validated brain health assessment platform...
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners
For the Sixth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC / ACCESS...
Evotec SE to announce first half-year results 2025 on 13 August 2025
HAMBURG, DE / ACCESS Newswire / August 6, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE0005664809,...
Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced...
Dxcover Strengthens Leadership with World-Class Scientific Advisors and Board Members
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,...
Dxcover Strengthens Leadership with World-Class Scientific Advisors and Board Members
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,...
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingGUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine,...
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingGUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine,...
Duly Health and Care Opens New Multi-Specialty Clinic in Schaumburg
Expanding access to high-quality, physician-directed care in the northwest suburbs DOWNERS GROVE, IL / ACCESS Newswire / August 4, 2025...
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial
Strategic CRO Partnership Supports Operational Readiness and Initiation of Upcoming Concussion StudySARASOTA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Oragenics,...
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic
CNSide available for the state of Texas in August 2025 Initial commercial focus on NCI-Designated Cancer Centers and large private...
Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
New clinical Precision Medicine population data demonstrates up to 84.6 Weeks (19.5 Months) ‘time saved’ by early-start ADAS-Cog13 difference: −5.43...